No English!
The app is no longer in English! Please restore this if possible. Thank you very much.
iScore AD
Published by:
SWISS4WARD EUROPE SL
Description
Die Bestimmung der Krankheitsaktivität beim atopischen Ekzem ist sehr zeitaufwändig, wird aber immer wichtiger zur Rechtfertigung der Therapie-Kosten gegenüber den Krankenkassen. Die vorliegende App erlaubt die Bestimmung des EASI (Eczema Area and Severity Index) innerhalb von 15 Sekunden.
Screenshots
iScore AD FAQ
-
Is iScore AD free?
Yes, iScore AD is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is iScore AD legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does iScore AD cost?
iScore AD is free.
-
What is iScore AD revenue?
To get estimated revenue of iScore AD app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in New Zealand yet.
Ratings History
iScore AD Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
266
|
iScore AD Installs
Last 30 days
iScore AD Revenue
Last 30 daysiScore AD Revenue and Downloads
Gain valuable insights into iScore AD performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
SWISS4WARD EUROPE SL
- Languages
- English
- Recent release
- 2.5.8 (2 years ago )
- Released on
- Jul 28, 2018 (6 years ago )
- Also available in
- Australia , Chile , Nigeria , Poland , Pakistan , Philippines , Peru , New Zealand , Norway , Netherlands , Romania , Malaysia , Mexico , Lebanon , Kazakhstan , Kuwait , South Korea , Japan , Portugal , India , Russia , Saudi Arabia , Sweden , Singapore , Slovenia , Slovakia , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Ecuador , Argentina , Austria , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , China , Colombia , Czechia , Germany , Denmark , Dominican Republic , Algeria , Italy , Estonia , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Croatia , Hungary , Indonesia , Ireland , Israel , United Arab Emirates
- Last Updated
- 1 day ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.